For the first time, we demonstrated that the decrease in p63/p73 expression together with the absence of functional p53 could underlie an increase in the fraction of polyploid cells, transformation rates, and the glycolytic NAD(P)H production in MFR-surviving cancer cells, providing conditions for radioresistance associated with EMT-like process activation. The gene discussed is TP53; the disease is cancer.